Antibody-profiling technologies for studying humoral responses to infectious agents.
about
New autoantibody detection technologies yield novel insights into autoimmune diseaseRedefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophyInvestigating a mystery disease: tales from a viral detectiveAntibody to the filarial antigen Wb123 reflects reduced transmission and decreased exposure in children born following single mass drug administration (MDA)Altered antibody profiles against common infectious agents in chronic diseaseQuantitative humoral profiling of the HIV-1 proteome in elite controllers and patients with very long-term efficient antiretroviral therapy.Ultrarapid Measurement of Diagnostic Antibodies by Magnetic Capture of Immune ComplexesSerological studies confirm the novel astrovirus HMOAstV-C as a highly prevalent human infectious agent.Synthetic biology for translational research.Rapid induction of autoantibodies during ARDS and septic shock.Analysis of layered assays and volume microarrays in stratified media.Recombinant expression of the AChR-alpha1 subunit for the detection of conformation-dependent epitopes in Myasthenia Gravis.Rhesus and human cytomegalovirus glycoprotein L are required for infection and cell-to-cell spread of virus but cannot complement each other.Luciferase immunoprecipitation systems for measuring antibodies in autoimmune and infectious diseases.Salivary anti-Ro60 and anti-Ro52 antibody profiles to diagnose Sjogren's SyndromeAntibody profiling of Borrelia burgdorferi infection in horsesA Vision for Investigating the Microbiology of Health and Disease.New technologies for studying the complexity of oral diseasesImmunodominant "asymptomatic" herpes simplex virus 1 and 2 protein antigens identified by probing whole-ORFome microarrays with serum antibodies from seropositive asymptomatic versus symptomatic individualsQuantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from JamaicaMixed vector immunization with recombinant adenovirus and MVA can improve vaccine efficacy while decreasing antivector immunity.Serological diagnosis of pulmonary Mycobacterium tuberculosis infection by LIPS using a multiple antigen mixture.LIPS arrays for simultaneous detection of antibodies against partial and whole proteomes of HCV, HIV and EBV.Microfluidic LIPS for serum antibody detection: demonstration of a rapid test for HSV-2 infectionMethods to measure vaccine immunity.Novel potential serological prostate cancer biomarkers using CT100+ cancer antigen microarray platform in a multi-cultural South African cohort.Searching for biomarkers: humoral response profiling with luciferase immunoprecipitation systems.The serological evidence in humans supports a negligible risk of zoonotic infection from porcine circovirus type 2.Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia.Emerging biomedical applications of synthetic biology.Diagnostics and Discovery in Viral Central Nervous System Infections.Antibody Engineering for Pursuing a Healthier FutureProgress and challenges associated with the development of ricin toxin subunit vaccines.Luciferase Immunoprecipitation System Assay, a Rapid, Simple, Quantitative, and Highly Sensitive Antibody Detection for Parasitic Diseases.Redefining environmental exposure for disease etiology
P2860
Q27000173-2153DC12-53A5-41D5-8BEC-6D794F037198Q27333247-8FBF17E8-4690-4439-9B12-7AB99AB36115Q28383301-1336AA65-E56B-47A1-8A89-83CF55ED96A2Q28484232-145519D2-C1AB-4C52-842C-172D777553BFQ28661374-8050AA1D-451C-4785-AEDC-5CC8954E0ED7Q33677727-4B32012D-AAC5-41E2-BD49-9BA8641A38A2Q33812635-AED68C1D-E8E0-4315-81C7-BB3A26F89BC9Q33988444-5CB071D9-8EB1-4EFB-8885-AB5B34EB1163Q34073961-4872E208-D8BE-46B1-9643-4026219FE55EQ34267557-3E23DC59-DBE0-4884-9388-8E8F3714B289Q34387163-860CCFF8-FF49-42DF-BBC9-03B255061C69Q34612779-1CC405AB-60B5-44C2-8D21-0CB9FEDB7C22Q34741938-30424645-863B-48C3-AFAE-54B6D2DF05FBQ35013894-E80AF5B8-7C26-4810-B6D0-1425DBDB22D6Q35073717-F755CDB5-9903-4668-B211-297DC405518DQ35191085-BD9923C0-48E8-42A9-9FDC-E2B9AA07318EQ35676182-EED559D2-20A9-4406-A329-AA46603F0DD8Q35678322-87B43476-967F-4E04-9884-EC6E06BC4B0CQ35868029-19705B2A-7987-4B8B-A368-5FD3A3FD3CFFQ35891629-590D9C00-640E-42A1-A7A9-06DC089381A7Q36142504-AEAD7769-71EA-4511-B62C-99410C9C74ABQ36142835-9D8E15C3-4D19-429F-A363-A9B90CF78995Q36196860-E21E33A6-7921-43EB-BE54-D0D678F7B557Q36311880-D69D084D-5E4E-4CCC-9CF7-87147DCBC681Q36423975-4342218E-80E3-4F7D-895F-A183CB8D5B1BQ37046496-1827E644-B3EA-44AF-AC05-F252DA63BF2BQ37281501-0DE6E6DF-D285-494D-AC4E-29285C451AF4Q37337197-ADBF58C8-E924-404E-B80B-118CCA519F35Q37613033-E851D760-43E0-40EF-9EC5-1E64FCC9E651Q37962354-B1FCCF2B-BF91-4D19-9ADE-C350CCD61508Q38567111-0EFA8BB2-4047-49F7-BAE0-E25D5CB4821EQ38731632-5EAA0804-88D9-4F0B-B159-BC0524AF16E6Q38783059-34CF235F-F62F-4E10-B471-71D363D1D5EDQ42328626-73E8D578-BAE5-4B3C-AA8C-EDE2FB19EC3DQ58776843-B7A8219F-098B-45AE-BE9D-6BEE9DF7FAE4
P2860
Antibody-profiling technologies for studying humoral responses to infectious agents.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Antibody-profiling technologies for studying humoral responses to infectious agents.
@ast
Antibody-profiling technologies for studying humoral responses to infectious agents.
@en
type
label
Antibody-profiling technologies for studying humoral responses to infectious agents.
@ast
Antibody-profiling technologies for studying humoral responses to infectious agents.
@en
prefLabel
Antibody-profiling technologies for studying humoral responses to infectious agents.
@ast
Antibody-profiling technologies for studying humoral responses to infectious agents.
@en
P2093
P2860
P921
P356
P1476
Antibody-profiling technologies for studying humoral responses to infectious agents.
@en
P2093
Brian L Han
Emily R Bush
Kathryn H Ching
Michael J Iadarola
Peter D Burbelo
P2860
P304
P356
10.1586/ERV.10.50
P577
2010-06-01T00:00:00Z